头颈癌诱导化疗毒性:骨骼肌质量的核心作用
纳入92例头颈癌患者,评估营养状况对多西他赛、顺铂和5-氟尿嘧啶诱导化疗耐受性的影响。治疗后BMI、血清白蛋白和营养风险指数均下降,52例(62%)出现至少1项≥3级毒性,治疗前骨骼肌质量指数是唯一预测毒性的因素(p=0.04),且不受BMI影响。
要点
- 治疗前骨骼肌质量指数是诱导化疗≥3级毒性的唯一预测因素(p=0.04)。
- 该预测作用不受体质指数影响。
- 52例(62%)患者出现至少1项≥3级毒性。
核心结论
- 低骨骼肌质量是头颈癌诱导化疗毒性的预测因素。
研究设计与样本
- 纳入92例头颈癌患者,评估营养状况对多西他赛、顺铂和5-氟尿嘧啶诱导化疗耐受性的影响。
- 毒性按常见不良事件术语标准评估,营养状况通过体质指数、血清白蛋白、营养风险指数及CT扫描第一腰椎水平的骨骼肌质量指数评估。
主要发现
- 治疗前平均体质指数22.7 ± 4.6 kg/m2,血清白蛋白38.7 ± 5.8 g/L,营养风险指数97.6 ± 10.6,骨骼肌质量指数36.4 ± 7.9 cm2/m2。
- 治疗后体质指数23 ± 4.5,血清白蛋白30.2 ± 7.1,营养风险指数88.1 ± 9.2。
- 诱导化疗期间52例(62%)患者出现至少1项≥3级毒性。
- 治疗前骨骼肌质量指数是毒性的唯一预测因素,且不受体质指数影响(p = 0.04)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To assess the impact of nutritional status on tolerance to induction chemotherapy by docetaxel, cisplatin and 5-fluorouracil (ICT) in head and neck cancer (HNC). METHODS: Ninety-two HNC patients were included. Toxicity was assessed according to common terminology criteria for adverse events. Nutritional status was assessed by body mass index (BMI), serum albumin, nutritional risk index (NRI), and CT scan (skeletal muscle mass index [SMI] at the first lumbar vertebral level). RESULTS: Before treatment, average BMI was 22.7 ± 4.6 kg/m2 , serum albumin 38.7 ± 5.8 g/L, NRI 97.6 ± 10.6, and SMI 36.4 ± 7.9 cm2 /m2 . After treatment, BMI was 23 ± 4.5, serum albumin 30.2 ± 7.1, and NRI 88.1 ± 9.2. During ICT, 52 (62%) patients developed at least one toxicity ≥ Grade 3. Pre-treatment SMI was the only predictive factor of toxicity irrespective of BMI (p = 0.04). CONCLUSION: Low skeletal muscle mass is a predictive factor of toxicity to ICT in HNC.
引用
- Lere-Chevaleyre A, Bernadach M, Lambert C, et al. Toxicity of induction chemotherapy in head and neck cancer: The central role of skeletal muscle mass. Head Neck. 2021. PMID: 34918416. doi:10.1002/hed.26954
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。